World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
51
Citations
27537
World Ranking
4099
National Ranking
162

Marjolein van Egmond publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Marjolein van Egmond sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 115 publications — 6th percentile

6% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Marjolein van Egmond D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Marjolein van Egmond sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 51 D-Index — 17th percentile

17% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Marjolein van Egmond is affiliated with VU University Medical Center in the Netherlands and has contributed extensively to the fields of medicine, immunology, and microbiology. Their research primarily focuses on immunology, oncology, molecular biology, radiology, nuclear medicine and imaging, and surgery.

The scientist's main topics of research include monoclonal and polyclonal antibodies research, immune cells in cancer, immune cell function and interaction, cancer immunotherapy and biomarkers, T-cell and B-cell immunology, colorectal cancer surgical treatments, and glycosylation and glycoproteins research.

Their recent papers illustrate a diverse range of immunology and cancer research subjects:

  • Augmented antibody-based anticancer therapeutics boost neutrophil cytotoxicity (2021), Journal of Clinical Investigation
  • The present and future of immunocytokines for cancer treatment (2022), Cellular and Molecular Life Sciences
  • IgA and FcαRI: Versatile Players in Homeostasis, Infection, and Autoimmunity (2021), ImmunoTargets and Therapy
  • Neutrophils as immune effector cells in antibody therapy in cancer (2022), Immunological Reviews
  • Mechanisms of colorectal liver metastasis development (2022), Cellular and Molecular Life Sciences

Frequent co-authors in van Egmond's work include Steven J. Oosterling, Mandy Gruijs, G.S.A. Abis, Hein B.A.C. Stockmann, and Gestur Vidarsson. These collaborations suggest ongoing partnerships in a variety of immunological and oncological research projects.

Their publications have frequently appeared in established venues such as Frontiers in Immunology, International Journal of Molecular Sciences, Scientific Reports, Cellular and Molecular Life Sciences, and Cancers. The range of journals reflects a broad involvement in both immunology and cancer research communities.

Best Publications

  • Guidelines for the use and interpretation of assays for monitoring autophagy

    Daniel J. Klionsky;Fabio C. Abdalla;Hagai Abeliovich;Robert T. Abraham

  • Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

    Daniel J. Klionsky;Kotb Abdelmohsen;Akihisa Abe;Joynal Abedin

  • Macrophages in skin injury and repair.

    Babak Mahdavian Delavary;Willem M. van der Veer;Marjolein van Egmond;Frank B. Niessen

  • Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

    Daniel J. Klionsky;Kotb Abdelmohsen;Akihisa Abe;Joynal Abedin

  • Antibody-mediated phagocytosis contributes to the anti-tumor activity of the therapeutic antibody daratumumab in lymphoma and multiple myeloma

    M. B. Overdijk;S. Verploegen;M. Bogels;M. van Egmond

  • IgA and the IgA Fc receptor.

    Marjolein van Egmond;Cora A Damen;Annemiek B van Spriel;Gestur Vidarsson

  • New insights in the pathogenesis of immunoglobulin A vasculitis (Henoch-Schönlein purpura).

    Marieke H. Heineke;Aranka V. Ballering;Agnès Jamin;Sanae Ben Mkaddem

  • CD47–signal regulatory protein-α (SIRPα) interactions form a barrier for antibody-mediated tumor cell destruction

    Xi Wen Zhao;Ellen M. van Beek;Karin Schornagel;Hans Van der Maaden

  • Macrophages eliminate circulating tumor cells after monoclonal antibody therapy.

    Nuray Gül;Liane Babes;Kerstin Siegmund;Rianne Korthouwer

  • Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356

    Daniel J. Klionsky;Kotb Abdelmohsen;Akihisa Abe;Joynal Abedin

  • Mac-1 (CD11b/CD18) is essential for Fc receptor-mediated neutrophil cytotoxicity and immunologic synapse formation.

    Annemiek B. van Spriel;Annemiek B. van Spriel;Jeanette H. W. Leusen;Jeanette H. W. Leusen;Marjolein van Egmond;Marjolein van Egmond;Henry B. P. M. Dijkman;Henry B. P. M. Dijkman

  • The perioperative period is an underutilized window of therapeutic opportunity in patients with colorectal cancer.

    Gerben J. van der Bij;Steven J. Oosterling;Robert H. J. Beelen;Sybren Meijer

  • Antibody-Dependent Phagocytosis of Tumor Cells by Macrophages: A Potent Effector Mechanism of Monoclonal Antibody Therapy of Cancer

    Nuray Gül;Marjolein van Egmond

  • IgA and FcαRI: Pathological Roles and Therapeutic Opportunities.

    Annelot Breedveld;Marjolein van Egmond

  • Detrimental dermal wound healing: what can we learn from the oral mucosa?

    Judith E. Glim;Marjolein van Egmond;Frank B. Niessen;Vincent Everts

  • A Novel Human IgA Monoclonal Antibody Protects against Tuberculosis

    Sucharitha Balu;Rajko Reljic;Melanie J. Lewis;Richard J. Pleass;Richard J. Pleass

  • Immature Neutrophils Mediate Tumor Cell Killing via IgA but Not IgG Fc Receptors

    Marielle A. Otten;Esther Rudolph;Michael Dechant;Cornelis W. Tuk

  • Human immunoglobulin A receptor (FcalphaRI, CD89) function in transgenic mice requires both FcR gamma chain and CR3 (CD11b/CD18).

    Marjolein van Egmond;A.J. Hanneke van Vuuren;H. Craig Morton;Annemiek B. van Spriel

  • Triggering Fc alpha-receptor I (CD89) recruits neutrophils as effector cells for CD20-directed antibody therapy.

    Bernhard Stockmeyer;Michael Dechant;Marjolein van Egmond;Alison L. Tutt

  • Macrophages direct tumour histology and clinical outcome in a colon cancer model.

    Steven J Oosterling;Gerben J van der Bij;Gerrit A Meijer;Cornelis W Tuk

Frequent Co-Authors

Jan G. J. van de Winkel
Jan G. J. van de Winkel Genmab (United States)
Gestur Vidarsson
Gestur Vidarsson University of Amsterdam
Sybren L. Meijer
Sybren L. Meijer University of Amsterdam
Evelina Gatti
Evelina Gatti Aix-Marseille University
Sergio Lavandero
Sergio Lavandero University of Chile
Felix Randow
Felix Randow MRC Laboratory of Molecular Biology
Leonidas C. Platanias
Leonidas C. Platanias Northwestern University
Hsing Jien Kung
Hsing Jien Kung Taipei Medical University
Jeanette H. W. Leusen
Jeanette H. W. Leusen Utrecht University
Beth Levine
Beth Levine The University of Texas Southwestern Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a degree in Immunology opens doors to diverse healthcare careers, often requiring advanced education and specialization. For those interested in nursing roles related to immunology research or clinical care, exploring affordable education options is crucial. Many students consider cheap psych np programs as a cost-efficient route to gain specialized knowledge and skills.

Higher degrees like a Doctor of Nursing Practice (DNP) offer expanded career opportunities and earning potential. Understanding the doctor of nursing practice salary by state can help prospective students make informed decisions about where to study and work.

For nurses aiming to enhance their expertise, transitioning to specialized roles is key. Those moving from family nurse practitioner roles may find guidance on acute care nurse practitioner certification particularly useful to expand their clinical scope in acute settings.

Additionally, accelerated degree options like the accelerated fnp program can expedite the path to becoming a Family Nurse Practitioner, making it an attractive option for immunology students seeking a quicker entry into advanced nursing roles.

Best Scientists Citing Marjolein van Egmond

Trending Scientists

Recently Published Articles